Global Biosimilar Development Services Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01244769

Publication Date:

January 11, 2024

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Biosimilar Development Services market size was valued at US$ 107840 million in 2023. With growing demand in downstream market, the Biosimilar Development Services is forecast to a readjusted size of US$ 220930 million by 2030 with a CAGR of 10.8% during review period.
The research report highlights the growth potential of the global Biosimilar Development Services market. Biosimilar Development Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biosimilar Development Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biosimilar Development Services market.
The main contents of Biosimilar Development Services include drug design and screening, pharmacodynamic research, pharmaceutical research, pharmacokinetic research, clinical trial program design and implementation, production process development and verification, etc. These services are designed to ensure that biosimilars are similar or identical to reference medicines in terms of mechanism of action, strength, dosage, safety and effectiveness.
With the rise of personalized medicine, Biosimilar Development will pay more attention to the specific needs of patients and conduct customized development for different patient groups to improve treatment effects and meet personalized needs.
With the rise of personalized medicine, Biosimilar Development will pay more attention to the specific needs of patients and conduct customized development for different patient groups to improve treatment effects and meet personalized needs.
Key Features:
The report on Biosimilar Development Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biosimilar Development Services market. It may include historical data, market segmentation by Type (e.g., Insulin, Anti-Cancer Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biosimilar Development Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biosimilar Development Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biosimilar Development Services industry. This include advancements in Biosimilar Development Services technology, Biosimilar Development Services new entrants, Biosimilar Development Services new investment, and other innovations that are shaping the future of Biosimilar Development Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biosimilar Development Services market. It includes factors influencing customer ' purchasing decisions, preferences for Biosimilar Development Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biosimilar Development Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biosimilar Development Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biosimilar Development Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biosimilar Development Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biosimilar Development Services market.
Market Segmentation:
Biosimilar Development Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Insulin
Anti-Cancer Drugs
Others
Segmentation by application
Cancer
Diabetes
Arthritis
Psoriasis
Neutropenia
Enzyme or Hormone Deficiency
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3P Bio
BioPharmaSpec
Charles River Laboratories
ICON
Intertek
JSR Life Sciences
Labcorp
Syneos Health
PPD Inc
Profacgen
Sartorius
SGS S.A.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Development Services Market Size 2019-2030
2.1.2 Biosimilar Development Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biosimilar Development Services Segment by Type
2.2.1 Insulin
2.2.2 Anti-Cancer Drugs
2.2.3 Others
2.3 Biosimilar Development Services Market Size by Type
2.3.1 Biosimilar Development Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biosimilar Development Services Market Size Market Share by Type (2019-2024)
2.4 Biosimilar Development Services Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Arthritis
2.4.4 Psoriasis
2.4.5 Neutropenia
2.4.6 Enzyme or Hormone Deficiency
2.4.7 Others
2.5 Biosimilar Development Services Market Size by Application
2.5.1 Biosimilar Development Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biosimilar Development Services Market Size Market Share by Application (2019-2024)
3 Biosimilar Development Services Market Size by Player
3.1 Biosimilar Development Services Market Size Market Share by Players
3.1.1 Global Biosimilar Development Services Revenue by Players (2019-2024)
3.1.2 Global Biosimilar Development Services Revenue Market Share by Players (2019-2024)
3.2 Global Biosimilar Development Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biosimilar Development Services by Regions
4.1 Biosimilar Development Services Market Size by Regions (2019-2024)
4.2 Americas Biosimilar Development Services Market Size Growth (2019-2024)
4.3 APAC Biosimilar Development Services Market Size Growth (2019-2024)
4.4 Europe Biosimilar Development Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Biosimilar Development Services Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biosimilar Development Services Market Size by Country (2019-2024)
5.2 Americas Biosimilar Development Services Market Size by Type (2019-2024)
5.3 Americas Biosimilar Development Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Development Services Market Size by Region (2019-2024)
6.2 APAC Biosimilar Development Services Market Size by Type (2019-2024)
6.3 APAC Biosimilar Development Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilar Development Services by Country (2019-2024)
7.2 Europe Biosimilar Development Services Market Size by Type (2019-2024)
7.3 Europe Biosimilar Development Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Development Services by Region (2019-2024)
8.2 Middle East & Africa Biosimilar Development Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Biosimilar Development Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biosimilar Development Services Market Forecast
10.1 Global Biosimilar Development Services Forecast by Regions (2025-2030)
10.1.1 Global Biosimilar Development Services Forecast by Regions (2025-2030)
10.1.2 Americas Biosimilar Development Services Forecast
10.1.3 APAC Biosimilar Development Services Forecast
10.1.4 Europe Biosimilar Development Services Forecast
10.1.5 Middle East & Africa Biosimilar Development Services Forecast
10.2 Americas Biosimilar Development Services Forecast by Country (2025-2030)
10.2.1 United States Biosimilar Development Services Market Forecast
10.2.2 Canada Biosimilar Development Services Market Forecast
10.2.3 Mexico Biosimilar Development Services Market Forecast
10.2.4 Brazil Biosimilar Development Services Market Forecast
10.3 APAC Biosimilar Development Services Forecast by Region (2025-2030)
10.3.1 China Biosimilar Development Services Market Forecast
10.3.2 Japan Biosimilar Development Services Market Forecast
10.3.3 Korea Biosimilar Development Services Market Forecast
10.3.4 Southeast Asia Biosimilar Development Services Market Forecast
10.3.5 India Biosimilar Development Services Market Forecast
10.3.6 Australia Biosimilar Development Services Market Forecast
10.4 Europe Biosimilar Development Services Forecast by Country (2025-2030)
10.4.1 Germany Biosimilar Development Services Market Forecast
10.4.2 France Biosimilar Development Services Market Forecast
10.4.3 UK Biosimilar Development Services Market Forecast
10.4.4 Italy Biosimilar Development Services Market Forecast
10.4.5 Russia Biosimilar Development Services Market Forecast
10.5 Middle East & Africa Biosimilar Development Services Forecast by Region (2025-2030)
10.5.1 Egypt Biosimilar Development Services Market Forecast
10.5.2 South Africa Biosimilar Development Services Market Forecast
10.5.3 Israel Biosimilar Development Services Market Forecast
10.5.4 Turkey Biosimilar Development Services Market Forecast
10.5.5 GCC Countries Biosimilar Development Services Market Forecast
10.6 Global Biosimilar Development Services Forecast by Type (2025-2030)
10.7 Global Biosimilar Development Services Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 3P Bio
11.1.1 3P Bio Company Information
11.1.2 3P Bio Biosimilar Development Services Product Offered
11.1.3 3P Bio Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 3P Bio Main Business Overview
11.1.5 3P Bio Latest Developments
11.2 BioPharmaSpec
11.2.1 BioPharmaSpec Company Information
11.2.2 BioPharmaSpec Biosimilar Development Services Product Offered
11.2.3 BioPharmaSpec Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioPharmaSpec Main Business Overview
11.2.5 BioPharmaSpec Latest Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Information
11.3.2 Charles River Laboratories Biosimilar Development Services Product Offered
11.3.3 Charles River Laboratories Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Charles River Laboratories Main Business Overview
11.3.5 Charles River Laboratories Latest Developments
11.4 ICON
11.4.1 ICON Company Information
11.4.2 ICON Biosimilar Development Services Product Offered
11.4.3 ICON Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ICON Main Business Overview
11.4.5 ICON Latest Developments
11.5 Intertek
11.5.1 Intertek Company Information
11.5.2 Intertek Biosimilar Development Services Product Offered
11.5.3 Intertek Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Intertek Main Business Overview
11.5.5 Intertek Latest Developments
11.6 JSR Life Sciences
11.6.1 JSR Life Sciences Company Information
11.6.2 JSR Life Sciences Biosimilar Development Services Product Offered
11.6.3 JSR Life Sciences Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 JSR Life Sciences Main Business Overview
11.6.5 JSR Life Sciences Latest Developments
11.7 Labcorp
11.7.1 Labcorp Company Information
11.7.2 Labcorp Biosimilar Development Services Product Offered
11.7.3 Labcorp Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Labcorp Main Business Overview
11.7.5 Labcorp Latest Developments
11.8 Syneos Health
11.8.1 Syneos Health Company Information
11.8.2 Syneos Health Biosimilar Development Services Product Offered
11.8.3 Syneos Health Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Syneos Health Main Business Overview
11.8.5 Syneos Health Latest Developments
11.9 PPD Inc
11.9.1 PPD Inc Company Information
11.9.2 PPD Inc Biosimilar Development Services Product Offered
11.9.3 PPD Inc Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 PPD Inc Main Business Overview
11.9.5 PPD Inc Latest Developments
11.10 Profacgen
11.10.1 Profacgen Company Information
11.10.2 Profacgen Biosimilar Development Services Product Offered
11.10.3 Profacgen Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Profacgen Main Business Overview
11.10.5 Profacgen Latest Developments
11.11 Sartorius
11.11.1 Sartorius Company Information
11.11.2 Sartorius Biosimilar Development Services Product Offered
11.11.3 Sartorius Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sartorius Main Business Overview
11.11.5 Sartorius Latest Developments
11.12 SGS S.A.
11.12.1 SGS S.A. Company Information
11.12.2 SGS S.A. Biosimilar Development Services Product Offered
11.12.3 SGS S.A. Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 SGS S.A. Main Business Overview
11.12.5 SGS S.A. Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂